TO: All record holders and beneficial holders of shares of NGM Biopharmaceuticals, Inc. ("NGM" or the "Company") common stock (Nasdaq: "NGM") who either received $1.55 per share in cash at the closing ...
WICHITA, Kan.--(BUSINESS WIRE)--Equity Bancshares, Inc. (NYSE: EQBK) (“Equity” or the “Company”) today announced the pricing of its underwritten public offering of 1,797,600 shares of its Class A ...
Lithium Americas (LAC) faces higher shareholder risk as DOE warrants/GM gain upside, timelines slip to 2028, and cash burn ...
Nektar Therapeutics (NKTR) shares popped 4% premarket on Wednesday after the biotechnology company launched a public offering of $300M of common shares and, in lieu of common stock to certain ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results